Notably, recent studies have reported CREB3L1, a critical member of CREB3 family, participate in cancer initiation and progression, and can serve as a promising clinical biomarker for cancer patients (Vellanki et al., 2013; Sampieri et al., 2019; Morishita et al., 2021). The gene discussed is CREB3; the disease is cancer.